72865-144-60 : NDC 2026 Code

72865-144-60 : Lamivudine And Zidovudine ( Lamivudine And Zidovudine )

Additionally :

You can get information about “72865-144-60” NDC code in 72865-144-60 in HTML format

HTML | 72865-144-60 in TXT (Plain Text) format

TXT | 72865-144-60 in PDF (Portable Document Format)

PDF | 72865-144-60 in XML format

XML formats.

NDC Code : 72865-144-60 – JSON Data Format

                
{
  "NDC": {
    "NDCCode": "72865-144-60",
    "PackageDescription": "60 TABLET, FILM COATED in 1 BOTTLE (72865-144-60) ",
    "NDC11Code": "72865-0144-60",
    "ProductNDC": "72865-144",
    "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
    "ProprietaryName": "Lamivudine And Zidovudine",
    "ProprietaryNameSuffix": null,
    "NonProprietaryName": "Lamivudine And Zidovudine",
    "DosageFormName": "TABLET, FILM COATED",
    "RouteName": "ORAL",
    "StartMarketingDate": "20200417",
    "EndMarketingDate": null,
    "MarketingCategoryName": "ANDA",
    "ApplicationNumber": "ANDA203259",
    "LabelerName": "XLCare Pharmaceuticals, Inc",
    "SubstanceName": "LAMIVUDINE; ZIDOVUDINE",
    "StrengthNumber": "150; 300",
    "StrengthUnit": "mg/1; mg/1",
    "Pharm_Classes": "Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleoside Reverse Transcriptase Inhibitors [MoA]",
    "DEASchedule": null,
    "Status": "Active",
    "LastUpdate": "2023-01-18",
    "PackageNdcExcludeFlag": "N",
    "ProductNdcExcludeFlag": "N",
    "ListingRecordCertifiedThrough": "20261231",
    "StartMarketingDatePackage": "20200417",
    "EndMarketingDatePackage": null,
    "SamplePackage": "N"
  }
}